ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on Sacituzumab Govitecan vs. Treatment of Physician’s Choice in Previously Treated mTNBC: Final Results From the Phase 3 ASCENT Study
By
ASCO 2022 Conference Coverage
FEATURING
Aditya Bardia
By
ASCO 2022 Conference Coverage
FEATURING
Aditya Bardia
642 views
June 21, 2022
Login to view comments.
Click here to Login
Breast